They found that the overexpression of DUSP1 upregulated P-glycoprotein expression, which facilitated the efflux of anticancer drugs, thereby leading to resistance in human ovarian cancer cells [64]. This evidence concerns the gene DUSP1 and ovarian carcinoma.